Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Genital Neoplasms, Female × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 320 Precursor Cell Lymphoblastic Leukemia-Lymphoma 77 Lymphoma 57 Leukemia 55 Neoplasms, Plasma Cell 54 Recurrence 46 Neoplasms 32 Vomiting 31 Lymphoma, Non-Hodgkin 30 Lymphoma, Mantle-Cell 26 Immunoglobulin Light-chain Amyloidosis 25 Burkitt Lymphoma 22 Nausea 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Waldenstrom Macroglobulinemia 19 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma, Follicular 18 Prostatic Neoplasms 16 Hodgkin Disease 16 Breast Neoplasms 14 Neoplasm Metastasis 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myeloid, Acute 11 Amyloidosis 10 Ovarian Neoplasms 9 Lymphoma, Large-Cell, Immunoblastic 9 Carcinoma, Non-Small-Cell Lung 9 Lymphoma, T-Cell, Cutaneous 8 Colonic Neoplasms 8 Renal Insufficiency 7

Interventions

Palliative Care 2 Gemcitabine 2 Carboplatin 2 temsirolimus 1 rucaparib 1 pembrolizumab 1 niraparib 1 liposomal doxorubicin 1 fosaprepitant 1 atezolizumab 1 argatroban 1 Topotecan 1 Thrombopoietin 1 Pemetrexed 1 Palonosetron 1 Paclitaxel 1 Ocoxin 1 Heparin, Low-Molecular-Weight 1 Educational Status 1 Dexamethasone 1 Darbepoetin alfa 1 Cognitive Behavioral Therapy 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01074697 2015-04-24

GAND-emesis

Odense University Hospital

Phase 3 Completed

Genital Neoplasms, Female, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡